Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1969 1
1975 1
1976 1
1982 1
1983 1
1986 1
1987 1
1989 1
1990 3
1992 1
1993 1
1994 2
1997 2
1998 3
2002 1
2004 3
2005 4
2006 8
2007 5
2008 9
2009 7
2010 4
2011 10
2012 5
2013 8
2014 9
2015 16
2016 17
2017 13
2018 14
2019 17
2020 14
2021 16
2022 14
2023 27
2024 22
2025 18
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Results by year

Filters applied: . Clear all
Page 1
A first-in-class EGFR-directed KRAS G12V selective inhibitor.
Stanland LJ, Huggins HP, Sahoo SS, Porrello A, Chareddy Y, Azam SH, Perry JL, Pallan PS, Whately K, Edatt L, Green WD, Fleming MC, Im J, Gutierrez-Ford C, Simmons I, Dawoud A, Zhou KI, Jayaprakash V, Sellers RS, Cruz G, Wielgus A, Milner J, Egli M, Bowers AA, Pecot CV. Stanland LJ, et al. Among authors: perry jl. Cancer Cell. 2025 Oct 13;43(10):1815-1832.e10. doi: 10.1016/j.ccell.2025.05.016. Epub 2025 Jun 19. Cancer Cell. 2025. PMID: 40541192 Free article.
Calibration-quality cancer nanotherapeutics.
Perry JL, Kai MP, Reuter KG, Bowerman C, Christopher Luft J, DeSimone JM. Perry JL, et al. Cancer Treat Res. 2015;166:275-91. doi: 10.1007/978-3-319-16555-4_12. Cancer Treat Res. 2015. PMID: 25895873 Review.
Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers.
Chareddy YS, Huggins HP, Sahoo SS, Stanland LJ, Gutierrez-Ford C, Whately KM, Edatt L, Azam SH, Fleming MC, Im J, Porrello A, Simmons I, Perry JL, Bowers AA, Egli M, Pecot CV. Chareddy YS, et al. Among authors: perry jl. J Clin Invest. 2025 Jul 22;135(19):e187204. doi: 10.1172/JCI187204. eCollection 2025 Oct 1. J Clin Invest. 2025. PMID: 40762837 Free PMC article.
Gastrointestinal organoids in the study of viral infections.
Gebert JT, Scribano F, Engevik KA, Perry JL, Hyser JM. Gebert JT, et al. Among authors: perry jl. Am J Physiol Gastrointest Liver Physiol. 2023 Jan 1;324(1):G51-G59. doi: 10.1152/ajpgi.00152.2022. Epub 2022 Nov 22. Am J Physiol Gastrointest Liver Physiol. 2023. PMID: 36414538 Free PMC article. Review.
Nanoparticulate immunotherapy for cancer.
Kapadia CH, Perry JL, Tian S, Luft JC, DeSimone JM. Kapadia CH, et al. Among authors: perry jl. J Control Release. 2015 Dec 10;219:167-180. doi: 10.1016/j.jconrel.2015.09.062. Epub 2015 Oct 10. J Control Release. 2015. PMID: 26432555 Review.
High-frame-rate full-vocal-tract 3D dynamic speech imaging.
Fu M, Barlaz MS, Holtrop JL, Perry JL, Kuehn DP, Shosted RK, Liang ZP, Sutton BP. Fu M, et al. Among authors: perry jl. Magn Reson Med. 2017 Apr;77(4):1619-1629. doi: 10.1002/mrm.26248. Epub 2016 Apr 21. Magn Reson Med. 2017. PMID: 27099178
221 results